New pill aims to heal scarred livers in common disease
Disease control
Completed
This study tested whether a drug called saroglitazar magnesium could help people with a serious form of fatty liver disease called NASH, which causes liver scarring. 189 adults with confirmed NASH and moderate scarring took either the drug or a placebo pill for 52 weeks. The main…
Phase: PHASE2 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Apr 02, 2026 00:56 UTC